Alexza Pharmaceuticals Inc. Retained Earnings
Alexza Pharmaceuticals Inc. had Retained Earnings of -$435.63 million as of 2016-03-31, per its 10-Q filed 2016-05-13.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2016-05-13
- 2016-03-31: Retained Earnings (Accumulated Deficit) -$435.63M.
- 2015-12-31: Retained Earnings (Accumulated Deficit) -$432.27M.
- 2015-09-30: Retained Earnings (Accumulated Deficit) -$429.25M.
- 2015-06-30: Retained Earnings (Accumulated Deficit) -$423.81M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2016-03-31 | -$435.63M 10-Q · filed 2016-05-13 |
| 2015-12-31 | -$432.27M 10-Q · filed 2016-05-13 |
| 2015-09-30 | -$429.25M 10-Q · filed 2015-11-05 |
| 2015-06-30 | -$423.81M 10-Q · filed 2015-08-06 |
| 2015-03-31 | -$411.36M 10-Q · filed 2015-05-11 |
| 2014-12-31 | -$410.96M 10-K · filed 2016-03-28 |
| 2014-09-30 | -$404.25M 10-Q · filed 2014-11-05 |
| 2014-06-30 | -$390.93M 10-Q · filed 2014-08-07 |
| 2014-03-31 | -$384.96M 10-Q · filed 2014-05-05 |
| 2013-12-31 | -$374.23M 10-K · filed 2015-03-13 |
| 2013-09-30 | -$368.54M 10-Q · filed 2013-11-06 |
| 2013-06-30 | -$356.12M 10-Q · filed 2013-08-14 |
| 2013-03-31 | -$355.32M 10-Q · filed 2013-05-14 |
| 2012-12-31 | -$334.61M 10-K · filed 2014-03-25 |
| 2011-12-31 | -$306.63M 10-K · filed 2013-03-26 |